Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05076448
Other study ID # 012012548111
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 30, 2014
Est. completion date February 11, 2023

Study information

Verified date October 2023
Source Pirogov Russian National Research Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study includes a retrospective and prospective study will enroll patients with pelvic venous disorders who have undergone pelvic vein surgery and endovascular interventions. Three groups of patients will be formed. The first will include patients who underwent open retroperitoneal resection of the gonadal veins and endoscopic trans- and retroperitoneal resection of the gonadal veins. The second group will include patients who underwent embolization of the gonadal veins with coils, the third - patients who underwent stenting of the common iliac veins, or stenting of the iliac veins in combination with embolization of the gonadic veins with coils. Evaluation of the effectiveness and safety of interventions on the pelvic veins will be carried out by assessing the effect of the intervention on pelvic pain, morphological and functional state of the pelvic veins. The assessment of the safety of interventions on the pelvic veins will be carried out by assessing the severity of post-procedural pain, the frequency of complications of operations on the pelvic veins, and complications of anesthesia. In addition, the duration of pelvic vein interventions will be compared with the length of time the patient is in hospital. Based on the data obtained, an algorithm will be proposed for determining the choice of the method of interventions on the pelvic veins in patients with pelvic venous disorders.


Description:

This study includes a retrospective and prospective study and will include patients with pelvic venous disorders (ovarian venous insufficiency, compression stenosis of the left or right common iliac vein) who underwent surgical and endovascular interventions on the pelvic veins during 2000-2022. The database of the local system "Interin" of the First City Hospital of Moscow (Russia) will be used, into which all information about patients with pelvic venous diseases during 2000-2021 was entered. In this study, the pelvic veins included the gonadal, parametric, uterine, common, external and internal iliac veins. Indications for intervention on the gonadal veins are symptoms and signs of pelvic venous disorder (pelvic pain, dyspareunia, heaviness in the hypogastric region, vulvar varicose veins) in combination with the expansion of the gonadal veins of more than 5 mm and reflux in them for more than 1 s. The indication for intervention on the left / right common iliac vein is the presence of compression stenosis of these veins of more than 50% in combination with symptoms and signs of pelvic venous disease. Three groups of patients will be formed. The first will include patients with ovarian venous insufficiency, dilation of the gonadal veins of more than 10 mm and reflux along them for more than 1 s, who underwent open retroperitoneal resection and endoscopic trans- and retroperitoneal resection of the gonadal veins. The second group will include patients with ovarian venous insufficiency, dilatation of the gonadal veins less than 10 mm and pelvic venous reflux for more than 1 s, who have undergone embolization of the gonadal veins with coils. The third will include patients with a combination of May-Thurner-Cockett syndrome and pelvic congestion syndrome who have stenting of the common iliac veins, or stenting of the iliac veins in combination with embolization of the gonadal veins with coils. Evaluation of the effectiveness and safety of interventions on the pelvic veins will be carried out by assessing the effect of the intervention on pelvic pain, morphological and functional state of the pelvic veins. A visual analogue scale will be used to assess the dynamics of pelvic pain after gonadal and iliac vein interventions. The assessment of the morphological and functional state will be carried out using the results of transabdominal and transvaginal duplex ultrasound (diameter of the pelvic veins, linear blood flow velocity through them, the presence of reflux in these veins and its duration). The assessment of the safety of interventions on the pelvic veins will be carried out by assessing the severity of post-procedural pain, the frequency of complications of operations on the pelvic veins, and complications of anesthesia. Postoperative / Postprocedural pain was assessed using a visual analogue scale. Complications of gonadal and iliac vein interventions were assessed within 1-30 days after surgery. Complications of gonadal vein resection included: 1. Wound infectious complications; 2. Thrombosis of non-targeted pelvic veins (parametric, uterine, internal iliac veins); 3. Bleeding with the formation of a retroperitoneal hematoma after surgery; 4. Massive bleeding during surgery; 5. Intestinal paresis (ileus). Complications of gonadal vein embolization with coils included: 1. Hematoma / bleeding at the access point; 2. Thrombosis of non-targeted pelvic veins (parametric, uterine, internal iliac veins); 3. Postembolization syndrome; 4. Protrusion of spirals; 5. Migration of spirals; 6. Allergic reactions to contrast agent or nickel. Complications of stenting of the common iliac vein included: 1. Hematoma / bleeding at the access point; 2. Stent thrombosis; 3. Migration of the stent; 4. Perforation of the iliac veins or inferior vena cava. In addition, the duration of pelvic vein interventions will be compared with the length of time the patient is in hospital. ased on this study of data, objective information will be obtained on the effectiveness and safety of interventions on the gonadal and iliac veins, and an algorithm will be proposed for determining the choice of the method of interventions on the pelvic veins in patients with pelvic venous disorders.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date February 11, 2023
Est. primary completion date January 30, 2023
Accepts healthy volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - the presence of pelvic venous disorder symptoms and signs (chronic pelvic pain, dyspareunia, discomfort/heaviness in the hypogastrium); - reflux in the gonadal, parametrial, uterine veins, according to duplex ultrasound scanning and ovarian venography or multislice computed venography (MSCV); - narrowing of the lumen of the left CIV greater than 50% with imaging of collateral veins by the radiological contrast studies Exclusion Criteria: - combined surgery on the veins and pelvic organs; comorbidities with ???

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Gonadal veins resection
Gonadal veins resection (GVR) was performed open, transperitoneal and retroperitoneal endoscopic methods under general anesthesia. Open GVR was performed in the Trendelenburg position, on the back with the operating table rotating 30° The retroperitoneal approach was employed in the left and/or right iliac region. The GV was mobilized for 10-12 cm and the vein was resected.. Transperitoneal GVR was performed with 3 ports were placed: one 10-mm port in the umbilical region, one 5-mm port in the left or right iliac region, and one 5-mm port 5 cm below the umbilicus. The GV was mobilized over a length of 10-12 cm and the vessel was resected. Retroperitoneal GVR was performed with the patient in a lateral position and in the reverse Trendelenburg position. A 10-mm camera port was installed in the lumbar region between the posterior superior iliac spine and the lower edge of the XII rib. The GV was mobilized over a length of 10-12 cm and the vessel was resected.
Gonadal vein embolization with coils
Procedure was performed under local anesthesia with 5.0-10.0 mL of 0.5% lidocaine solution with a patient under intravenous sedation. For the left GV embolization, the transfemoral approach was used, while for the right or both GV embolization, the transjugular approach was used. The vein puncture was performed under ultrasound guidance. The 5F multipurpose angiographic catheters (Cordis; USA), standard 'moving core' J .035" guidewire, and an angled hydrophilic guidewire (Radiofocus; Terumo Corp., Japan) were used. For the GV occlusion, the pushable 0.035" standard stainless steel coils (Gianturco; William Cook, Bjæverskov, Denmark) and 0.035" coils made of Inconel with interwoven long collagen fibrils (MReye; Cook Medical Inc., Bloomington, USA) were used. The diameter of coils was 8-12 mm, and the length was 10-20 cm.
Endovascular stenting of the common iliac vein (CIV)
After providing local anesthesia, the left common femoral vein was punctured, a 0.035" guidewire was inserted into the inferior vena cava (IVC), and then a 10F introducer was installed. A balloon catheter was introduced over the guidewire in the left CIV (XXL balloon, Boston Scientific, diameter 14-18, length 40-60 mm), and double balloon dilation of the vessel was performed with a pressure of 6-8 atm. Then, a delivery system was advanced to the area of stenosis in the left CIV, and stent was deployed at the level of confluence of the left CIV and inferior vena cava (IVC) or with a protrusion in the IVC of no more than 1 cm. For better fixation of stent in the venous lumen and prevention of its displacements and migration, a balloon post-dilatation of the stented vessel was performed. In case of residual stenosis, the balloon angioplasty was performed.

Locations

Country Name City State
Russian Federation Department of Faculty Surgery ?1 Moscow

Sponsors (1)

Lead Sponsor Collaborator
Pirogov Russian National Research Medical University

Country where clinical trial is conducted

Russian Federation, 

References & Publications (4)

Lakhanpal G, Kennedy R, Lakhanpal S, Sulakvelidze L, Pappas PJ. Pelvic venous insufficiency secondary to iliac vein stenosis and ovarian vein reflux treated with iliac vein stenting alone. J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1193-1198. doi: 1 — View Citation

Maratto S, Khilnani NM, Winokur RS. Clinical Presentation, Patient Assessment, Anatomy, Pathophysiology, and Imaging of Pelvic Venous Disease. Semin Intervent Radiol. 2021 Jun;38(2):233-238. doi: 10.1055/s-0041-1729745. Epub 2021 Jun 3. — View Citation

Meissner MH, Khilnani NM, Labropoulos N, Gasparis AP, Gibson K, Greiner M, Learman LA, Atashroo D, Lurie F, Passman MA, Basile A, Lazarshvilli Z, Lohr J, Kim MD, Nicolini PH, Pabon-Ramos WM, Rosenblatt M. The Symptoms-Varices-Pathophysiology classificatio — View Citation

Possover M, Khazali S, Fazel A. Pelvic congestion syndrome and May-Thurner syndrome as causes for chronic pelvic pain syndrome: neuropelveological diagnosis and corresponding therapeutic options. Facts Views Vis Obgyn. 2021 Jun;13(2):141-148. doi: 10.5205 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Complications of anesthesia Hematoma, vascular damage, pulmonary complications. 1 and 5 days after the intervention on the pelvic veins
Other Wound infectious complications It was assessed visually, on the basis of examination and palpation of the puncture point of the main vein or postoperative wounds. 5 days after the intervention on the pelvic veins
Primary Change in the severity of pelvic pain The visual analogue scale is a line 10 cm long. Each centimeter corresponds to 1 point: 0 points - no pain, 10 points - maximum pain. Higher scores on the scale correspond to poorer results. At baseline and 12 months after pelvic vein intervention.
Secondary Change in the diameter of the pelvic veins The diameter of the pelvic veins was measured using duplex ultrasound. At baseline and 12 months after pelvic vein intervention.
Secondary Change in the duration of pelvic venous reflux Pelvic venous reflux was measured using duplex ultrasound. Reflux duration of more than 1 s was considered pathological. At baseline and 12 months after pelvic vein intervention.
Secondary Postprocedural pain The visual analogue scale is a line 10 cm long. Each centimeter corresponds to 1 point: 0 points - no pain, 10 points - maximum pain. Higher scores on the scale correspond to poorer results. 1 day, 5 days, 1 and 12 months after the intervention on the pelvic veins.
Secondary Pelvic vein thrombosis Pelvic vein thrombosis was detected using duplex ultrasound. 1 and 5 days after the intervention on the pelvic veins
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03262987 - Color Doppler U/S vs MSCT Venography in May-Thurner Syndrome N/A
Active, not recruiting NCT04580160 - Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System N/A
Recruiting NCT05628948 - Vascular Lab Resource (VLR) Biorepository
Recruiting NCT04067505 - Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study Phase 3
Completed NCT06180122 - The Use and Reproducibility of Duplex Ultrasound to Provide Indices of Left Common Iliac Vein Diameter N/A
Completed NCT02655887 - BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease N/A
Recruiting NCT02584374 - Balloon Test for Iliac Vein Compression N/A
Recruiting NCT02240914 - Vascular Ultrasound Versus Intravascular Ultrasound for Diagnosing Iliac Vein Obstruction N/A
Completed NCT02149212 - Iliac Vein Stenting in Advanced Chronic Venous Insufficiency Phase 4
Completed NCT01846780 - Treadmill Pilot Study (Invasive Pressure Measurements in PTS) N/A
Not yet recruiting NCT05409781 - Prevalence of May-Thurner Syndrome in 1st-degree Relatives of Symptomatic Patients
Completed NCT01206751 - Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation N/A